GCG and fatty liver disease: Of the eight included studies, three assessed changes in hepatic fat content following GLP1-RA treatment, of which all reported correlations between weight loss and decreases in hepatic fat content (32, 35, 36), lending support for the role of weight loss on hepatic steatosis.